SNDX · Healthcare · $1.7B
Pre-market $18.89+0.48%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출 7,300만 달러로 전 분기 6,500만 달러 대비 다시 성장세로 돌아왔어요.”
In the company's words · 2026 2분기 earnings call